CHA
ARKG icon

Carmichael Hill & Associates’s ARK Genomic Revolution ETF ARKG Stock Holding History

Carmichael Hill & Associates’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$2.56K Hold
100
– – ﹤0.01% 695
2024
Q2 		$2.35K Hold
100
– – ﹤0.01% 690
2024
Q1 		$2.88K Hold
100
– – ﹤0.01% 667
2023
Q4 		$3.28K Hold
100
– – ﹤0.01% 677
2023
Q3 		$2.79K Hold
100
– – ﹤0.01% 679
2023
Q2 		$3.41K Buy
+100
New +$3.14K ﹤0.01% 667

Other funds holding ARKG

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Carmichael Hill & Associates's ARKG Position: Q3 2024 in Review

Carmichael Hill & Associates held its ARK Genomic Revolution ETF (ARKG) position steady in Q3 2024 at 100 shares worth $2.56K. The position accounts for ﹤0.01% of the portfolio, ranked #695.

Carmichael Hill & Associates first reported a position in ARKG in Q2 2023 and has held it in 6 quarters since. The position peaked at $3.41K in Q2 2023. 238 funds tracked by Wall St. Rank hold ARKG as of Q3 2024.

  • Carmichael Hill & Associates held 100 shares of ARK Genomic Revolution ETF worth $2.56K as of Q3 2024.
  • Carmichael Hill & Associates left its ARK Genomic Revolution ETF share count unchanged in Q3 2024.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Carmichael Hill & Associates's portfolio in Q3 2024, its #695 holding.
  • Carmichael Hill & Associates first reported a position in ARK Genomic Revolution ETF in Q2 2023 and has held it in 6 quarters since.
  • Carmichael Hill & Associates's ARK Genomic Revolution ETF position peaked at $3.41K in Q2 2023.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.